BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Point72 Asset Management, L.P. 2,758,813$19,532,3960.06%
PROFUND ADVISORS LLC 136,652$967,4960.05%
FOX RUN MANAGEMENT, L.L.C. 25,476$180,3700.05%
BNP Paribas Asset Management Holding S.A. 2,390,948$16,9280.05%
ExodusPoint Capital Management, LP 750,053$5,3100.05%
UBS OCONNOR LLC 241,820$1,712,0860.04%
TWO SIGMA ADVISERS, LP 2,368,912$16,771,8970.04%
Cypress Wealth Services, LLC 20,000$141,6000.04%
Inspire Investing, LLC 43,070$304,9360.04%
FRANKLIN STREET ADVISORS INC /NC 60,000$4250.04%
XTX Topco Ltd 31,833$225,3780.04%
Pictet Asset Management Holding SA 4,192,300$29,681,4840.04%
Rafferty Asset Management, LLC 807,888$5,719,8470.03%
Cubist Systematic Strategies, LLC 650,240$4,603,6990.03%
TWO SIGMA INVESTMENTS, LP 1,756,145$12,433,5070.03%
PANAGORA ASSET MANAGEMENT INC 727,480$5,150,5580.03%
Quantbot Technologies LP 64,100$453,8280.03%
Arete Wealth Advisors, LLC 23,300$164,9640.03%
Northeast Financial Consultants Inc 60,633$429,2820.03%
MOODY NATIONAL BANK TRUST DIVISION 52,046$368,4860.02%
External links

This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.